EGFR and interstitial lung disease: Treatment with EGFR-TKIs was significantly associated with ILD with a ROR of 24.61 (95% CI: 21.65–27.98), a PRR of 8.94, an IC: 3.03 (IC025: 1.36–4.7) and an EBGM of 8.19 (95% CI: 7.35–9.11).